Thomas Catinazzo Relay Therapeutics, Inc. (RLAY) insider trading activity
Thomas Catinazzo is Chief Financial Officer of Relay Therapeutics, Inc.. Currently has a direct ownership of 355,376 shares of RLAY, which is worth approximately $1.35 Million. The most recent transaction as insider was on Mar 26, 2021, when has been sold 15,870 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
355K
5.12%
3M change
7.55%
12M change
Total Value Held
$1.35 Million
TC
Thomas Catinazzo
Chief Financial Officer
Cambridge, MA